๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome

โœ Scribed by Dudley Robinson; Linda Cardozo; Gerben Terpstra; John Bolodeoku; the Tamsulosin Study Group


Book ID
109053527
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
106 KB
Volume
100
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A multicentre double-blind placebo-contr
โœ T. Darcis; M. Ferreri; J. Natens; B. Burtin; P. Deram ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 513 KB

The efficacy of hydroxyzine was investigated in 110 patients suffering from generalized anxiety, in a double-blind placebo controlled multicentre study. Oral hydroxyzine 50mg/day for four weeks significantly improved standard measurements of anxiety compared with placebo control. These improvements

A multicentre, randomized, double-blind,
โœ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre